The Army on Wednesday detailed the timeline for its newly approved plan to upgrade its Strykers with a 30mm weapons platform, which will include holding integration tests starting this summer and awarding a production contract for a Medium Caliber Weapon System in fiscal year 2020.
The Stryker Lethality upgrade is expected to total $907 million over seven years with the goal of fielding 294 MCWS platforms, according to a Request for Quotations notice.
Phase 1 of the Army’s effort to outfit its Double V-Hull Strykers with a 30mm weapon will open with up to eight contracts to participate in a Design Integration Study from this June through September 2020.
Participating vendors will be asked to integrate a government-provided XM813 30mm gun on a DVH Stryker during the study.
“In parallel to Phase 1, [Program Manager-Stryker Brigade Combat Team] intends to release a subsequent full and open competition RFP for a production and support contract for the MCWS, which will require the submission of a production representative system sample,” officials wrote in the notice.
Officials said the Army is still finalizing the evaluation criteria has for the eventual MCWS production competition, while adding that determining factors will likely include meeting tiered requirements and meeting a high manufacturing readiness level.
The production contract is set to be awarded in FY ’20, and will include a five-year base deal for full-rate production orders followed by three one-year options.
The Army is likely to spend $384.7 million in the first year of the Stryker Lethality program, which will total $907 million over the total seven years.
The eventual vendor is expected to produce 294 MCWS platforms for DVH Strykers, with the Army looking to manufacture 169 systems over two productions orders in the program’s first year.
Following initial production, officials wrote the Army will then field 83 weapons three years in a row before delivering a final 45 systems.
Officials expect all participating companies in the Design Integration Study to submit a bid for the phase two production contract, adding that companies who are not selected for the study will likely have a more difficult opportunity pursuing the MCWS award.